Screening colorectal tumor-associated fibroblasts using dual-channel THz biosensor
Abstract
In clinical oncology, label-free identification of colorectal tumor-associated fibroblast (CAF) subtypes is challenging. In this work, a terahertz (THz) metasurface exhibiting dual channels of probation, quasi-bound states in the continuum (q-BICs) and electromagnetically induced transparency (EIT), is used to screen CAF subtypes in colorectal tumors. When impinging light is polarized along x axis, the pro-tumorigenic myofibroblasts (myCAFs) cause frequency red-shift of q-BIC resonances compared to intestinal epithelial cells, while anti-tumorigenic antigen-presenting CAFs (apCAFs) result in blueshift. Similarly, for EIT modes, when light is polarized along the orthogonal polarization, myCAFs result in a frequency red-shift while apCAFs result in blueshift. These frequency shifts are attributed to the dielectric environment variation due to the surface hall-marks of CAFs. To validate our results, we conducted flow cytometry and gene expression analyses that confirmed distinct hallmarks of myCAFs and apCAFs, consistent with the resonance frequency shifts observed in THz metasurface measurements. Our findings demonstrate a label-free and cost-effective method for screening CAF subtypes using two-parameters—q-BICs and EIT—which can help speed up cancer diagnosis.
Related
- Integrated virtual screening and in vitro evaluation identify potential c-Myc/max complex inhibitors for colorectal cancer
- Electrochemical detection of hepatitis B virus DNA: a biosensor based on MnO2/MWCNT/AgNPs composite material
- Miniaturized biosensor platforms for early detection of neurodegenerative diseases and their potential for clinical translation
- Smartphone-based colorimetric glucose biosensor using peroxidase-like activity of bimetallic catalyst supported onto graphitic carbon nitride nanosheets
- Cardiolipin-Based Electrochemical Biosensor for Non-treponemal Antibody Detection Using Screen-Printed Electrodes: A Proof-of-Concept Study
BibTeX
@article{xu2026screening,
title = {{Screening colorectal tumor-associated fibroblasts using dual-channel THz biosensor}},
author = {Hongji Xu and Ruiqi Gu and Arthur Georg Serville Torvund and Iver Grønlien and Angelos Xomalis and Hai Son Nguyen and Zhengping Yu and Zhenyu Zhao},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117735},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03116-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Screening colorectal tumor-associated fibroblasts using dual-channel THz biosensor
AU - Hongji Xu
AU - Ruiqi Gu
AU - Arthur Georg Serville Torvund
AU - Iver Grønlien
AU - Angelos Xomalis
AU - Hai Son Nguyen
AU - Zhengping Yu
AU - Zhenyu Zhao
PY - 2026
DA - 2026/10/19
JO - iScience
DO - 10.1016/j.isci.2026.117735
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03116-0
AB - In clinical oncology, label-free identification of colorectal tumor-associated fibroblast (CAF) subtypes is challenging. In this work, a terahertz (THz) metasurface exhibiting dual channels of probation, quasi-bound states in the continuum (q-BICs) and electromagnetically induced transparency (EIT), is used to screen CAF subtypes in colorectal tumors. When impinging light is polarized along x axis, the pro-tumorigenic myofibroblasts (myCAFs) cause frequency red-shift of q-BIC resonances compared to intestinal epithelial cells, while anti-tumorigenic antigen-presenting CAFs (apCAFs) result in blueshift. Similarly, for EIT modes, when light is polarized along the orthogonal polarization, myCAFs result in a frequency red-shift while apCAFs result in blueshift. These frequency shifts are attributed to the dielectric environment variation due to the surface hall-marks of CAFs. To validate our results, we conducted flow cytometry and gene expression analyses that confirmed distinct hallmarks of myCAFs and apCAFs, consistent with the resonance frequency shifts observed in THz metasurface measurements. Our findings demonstrate a label-free and cost-effective method for screening CAF subtypes using two-parameters—q-BICs and EIT—which can help speed up cancer diagnosis.
SN - 2589-0042
ER -